Sign in
Taking peopleNo phase

Iron treatment before heart surgery in people with low iron or anemia

Observes iron correction before heart surgery and its link to fewer transfusions.

Key facts

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Patient Blood Management in Patients Scheduled for Cardiac Surgery
Status
Recruiting
People taking part
464 people, planned
Started
24 Feb 2025
Expected to end
28 Feb 2027
Type of study
Observational, 3 groups
Treatments tested
  • Iron
Record updated
10 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are scheduled for planned heart surgery. Low iron levels are checked and treated with iron before surgery.

Age
18 years and older
Sex
All sexes
Disease stage
Scheduled for planned (elective) heart surgery

Main reasons for not taking part

  • Pregnancy
  • Being on dialysis
  • Not wanting to take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • all adult patients scheduled for elective cardiac surgery

Who cannot take part

  • pregnancy
  • dyalisis
  • patient's refusal

This trial is currently available in Italy.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The ICARUS 2 study has the general objective of collecting data in patients undergoing cardiac surgery; in our centre, in order to optimize and improve hemoglobin values, a team of haematologists, assisted by cardio anesthetists and cardiac surgeons, will evaluate the blood tests of patients scheduled for elective cardiac surgery in order to correct any states of hypoferritinemia (low iron in the blood) to promote recovery from blood losses related to cardiac surgery. This objective is strongly encouraged by the good use of blood programs currently in force at our foundation.

Read full original descriptionShow less

In particular, the research presented here intends to demonstrate a reduction in the number of intra- and post-operative transfusions.

The 3 groups in the trial

  • Prospectic cohort

    patients scheduled for cardiac surgery who fulfil the inclusion criteria

    Treatment: Iron

  • retrospective cohort ICARUS 1

    patients scheduled for cardiac surgery (2021) with a known iron status, treated if indicated 1 or 2 days before surgery with iron supplementation.

  • retrospective cohort

    patients scheduled for cardiac surgery (2019-2020)with an unknown iron status and never treated with iron supplementation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Patient Blood Management in Cardiac Surgical Patients: the ICARUS-2 Study
Plain-language title
Iron treatment before heart surgery in people with low iron or anemiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
10 September 2026